Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLKR201 Phase 1 Study in Healthy Adults
NCT07501039Phase 1Recruiting
- Sponsor
- Formation Bio
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of LNK01006 (3 arms), sponsored by Formation Bio. Primary endpoints: Number of Participants with Treatment-Emergent Adverse Events, Change From Baseline in Clinical Laboratory Parameters and 6 more. Started Apr 2026; status: recruiting.
02
Drugs
LNK01006
Beyond the preview
Go deeper on NCT07501039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07501039.